Handelsbanken Fonder
DAWN

Handelsbanken Fonder’s Day One Biopharmaceuticals DAWN Stock Holding History

Handelsbanken Fonder’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31,500
Closed -$250K – 1524
2025
Q1 		$250K Hold
31,500
– – ﹤0.01% 1453
2024
Q4 		$399K Buy
31,500
+4,500
+17% +$62.6K ﹤0.01% 1379
2024
Q3 		$376K Buy
27,000
+3,900
+17% +$55.6K ﹤0.01% 1344
2024
Q2 		$318K Buy
23,100
+5,700
+33% +$83.4K ﹤0.01% 1363
2024
Q1 		$287K Hold
17,400
– – ﹤0.01% 1396
2023
Q4 		$254K Buy
+17,400
New +$211K ﹤0.01% 1450

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Handelsbanken Fonder's DAWN Position: Q2 2025 in Review

Handelsbanken Fonder sold out of Day One Biopharmaceuticals (DAWN) in Q2 2025, closing a stake of 31,500 shares — an estimated $250K sold.

Handelsbanken Fonder first reported a position in DAWN in Q4 2023 and held it in 6 quarters. The position peaked at $399K in Q4 2024. 174 funds tracked by Wall St. Rank hold DAWN as of Q2 2025.

  • Handelsbanken Fonder reported no remaining Day One Biopharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Handelsbanken Fonder sold 31,500 Day One Biopharmaceuticals shares in Q2 2025, an estimated $250K.
  • Handelsbanken Fonder first reported a position in Day One Biopharmaceuticals in Q4 2023 and held it in 6 quarters.
  • Handelsbanken Fonder's Day One Biopharmaceuticals position peaked at $399K in Q4 2024.
  • 174 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2025.

Based on Handelsbanken Fonder's 13F filing for Q2 2025, filed 12 Aug 2025.